Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Shanghai Haohai Biological Technology Co., Ltd. Class H ( (HK:6826) ) has shared an announcement.
Shanghai Haohai Biological Technology Co., Ltd. has announced proposed amendments to its Articles of Association, which include abolishing the supervisory committee and transferring its responsibilities to the audit committee. These changes align with recent regulatory updates in China and Hong Kong, aiming to streamline governance structures and incorporate electronic voting and hybrid shareholder meetings. The amendments are subject to shareholder approval at the upcoming annual general meeting.
More about Shanghai Haohai Biological Technology Co., Ltd. Class H
Shanghai Haohai Biological Technology Co., Ltd. is a company based in China, operating in the biotechnology industry. The company focuses on developing and providing biological materials and medical devices.
Average Trading Volume: 585,957
Technical Sentiment Signal: Sell
Current Market Cap: HK$12.06B
For a thorough assessment of 6826 stock, go to TipRanks’ Stock Analysis page.